Structural Approaches to Cancer Drug Development

Affiliations

Comment

Bruce Chabner et al. N Engl J Med. 2015.

. 2015 Jul 30;373(5):402-3.

doi: 10.1056/NEJMp1503567.

¹ From Massachusetts General Hospital, Boston (B.C.); and Sanofi Aventis, Cambridge, MA (V.R.).

Erratum in

Focus on Research: Structural Approaches to Cancer Drug Development.
[No authors listed] [No authors listed] N Engl J Med. 2015 Sep 3;373(10):982. doi: 10.1056/NEJMx150031. N Engl J Med. 2015. PMID: 26332565 No abstract available.

No abstract available

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
Tap WD, Wainberg ZA, Anthony SP, Ibrahim PN, Zhang C, Healey JH, Chmielowski B, Staddon AP, Cohn AL, Shapiro GI, Keedy VL, Singh AS, Puzanov I, Kwak EL, Wagner AJ, Von Hoff DD, Weiss GJ, Ramanathan RK, Zhang J, Habets G, Zhang Y, Burton EA, Visor G, Sanftner L, Severson P, Nguyen H, Kim MJ, Marimuthu A, Tsang G, Shellooe R, Gee C, West BL, Hirth P, Nolop K, van de Rijn M, Hsu HH, Peterfy C, Lin PS, Tong-Starksen S, Bollag G. Tap WD, et al. N Engl J Med. 2015 Jul 30;373(5):428-37. doi: 10.1056/NEJMoa1411366. N Engl J Med. 2015. PMID: 26222558 Clinical Trial.